Tag Archive for Zinzino

Zinzino Preliminary Sales Report February 2026

Zinzino group revenue increased with a total of 32 %, compared with the previous year.
The revenue in February for Zinzino‘s sales markets increased by 32 % and amounted to SEK 281.1 (212.7) million. Faun Pharma’s external sales increased and amounted to SEK 5.2 (4.2) million. Overall, the Group increased revenues by 32 % to SEK 286.3 (216.9) million compared with the previous year.
Accumulated revenue for January – February 2026 increased by 26 % to SEK 568.6 (450.8) million.
Revenues were distributed as follows:

Regions, MSEK
26-Feb
25-Feb
Change
YTD 2026
YTD 2025
Change

The Nordics
22.5
24.8
-9%
50.1
50.5
-1%

Central Europe
81.8
57.4
43%
171.0
126.8
35%

East Europe
26.2
29.0
-10%
55.9
63.2
-12%

South & West Europe
50.2
37.8
33%
97.2
82.0
19%

The Baltics
8.5
8.8
-3%
18.9
19.3
-2%

North America
67.5
32.5
108%
109.9
53.8
104%

South America
3.6
1.2
200%
7.5
2.1
257%

Asia-Pacific
18.6
19.7
-6%
41.7
41.2
1%

Africa
2.2
1.5
47%
4.1
3.0
37%

Zinzino
281.1
212.7
32%
556.3
441.9
26%

Faun Pharma
5.2
4.2
24%
12.3
8.9
38%

Zinzino Group
286.3
216.9
32%
568.6
450.8
26%

Countries in regions:

The Nordics: Denmark, Faroe Island, Finland, Iceland, Norway, Sweden
Central Europe: Austria, Germany, Switzerland
East Europe: Czech Republic, Slovakia, Hungary, Poland, Romania
South & West Europe: Cyprus, France, Greece, Italy, Luxembourg, Malta, Netherlands, Slovenia, Spain, United Kingdom, Belgium, Ireland, Serbia, Turkey, Canary Islands
The Baltics: Estonia, Latvia, Lithuania
North America: Canada, USA, Mexico
South America: Peru, Colombia
Asia-Pacific: Australia, Hong Kong, India, Malaysia, Singapore, Taiwan, Thailand, China, Philippines, South Korea
Africa: South Africa

About Zinzino
Zinzino AB (publ) (ZZ-B.ST) is a global direct-sales company from Scandinavia specializing in test-based, personalized nutrition and scientific skincare. It is a public limited company with its shares listed on Nasdaq First North Premier Growth Market.
Zinzino’s scientifically proven

Read more...

Zinzino Publishes 2025 Year-End Report: 51% Growth

Increases Dividend By 50% To SEK 6 After High Growth And Significant Improvement In Profitability. 
Zinzino AB (publ) (ZZ-B.ST), a global direct-sales company, reports that revenue for the fourth quarter of 2025 amounted to SEK 1,035.3 (713.5) million, corresponding to 45% (35%) growth compared with the same period last year. In local currencies, revenue for the fourth quarter increased by 52% compared with the corresponding period last year. EBITDA rose to SEK 175.2 (72.9) million after the EBITDA margin increased to 16.9% (10.2%). The improved EBITDA margin compared to the corresponding period last year was mainly due to stronger gross profit and increased synergies, primarily related to the acquisition of Zurvita.
During the quarter, Zinzino acquired 35% of the shares in Xion International Group with the aim of producing algae using bioreactors, thereby securing a sustainable future supply of omega-3 for the company’s main product, BalanceOil. In addition, the assets of the direct sales company Sanki were acquired to increase distribution power in North and South America, and the Gut Health Test was launched.
For the full year 2025, total revenue amounted to SEK 3,337.5 (2,207.8) million, corresponding to 51% (25%) growth compared with the previous year. EBITDA amounted to SEK 443.4 (250.7) million

Read more...

Zinzino Announces Peru as Next Step in Global Expansion

Zinzino is pleased to announce that it has launched its operations in Peru, as of February 10th, 2026.
Gothenburg, Sweden – Zinzino AB (publ) (ZZ-B.ST), a leading global direct selling company, reports that the company continues to strengthen its presence in Latin America with the launch of operations in Peru, which has generated monthly sales of approximately SEK 1.5 million through the company’s global web shop. The expansion builds on the company’s established success in existing Latin American markets, creating strong cross-border synergies for both partners and customers.
Peru offers attractive conditions for direct selling business, with a growing entrepreneurial culture and increasing demand for flexible income opportunities. At the same time, consumer interest in health, preventive care, and personalised nutrition solutions are rising, supporting long-term market potential for Zinzino’s science-based concept.

“Peru is a natural next step in our Latin American growth,”

says Dag Bergheim Pettersen, CEO of Zinzino.

“We see strong potential for our Peruvian Partners to build long-term success with our test-based concept.”

The launch will enable Zinzino’s Independent Partners to leverage the company’s existing regional infrastructure and experience as they develop the business locally. Zinzino’s digital platform and business model are well aligned with the Peruvian market, where digital commerce continues to expand

Read more...

Zinzino Publishes Preliminary January 2026 Sales Report

Zinzino group revenue increased with a total of 20%, compared with the previous year.
Gothenburg, Sweden – Zinzino AB (publ) (ZZ-B.ST), a leading global direct selling company, reports that the revenue in January for Zinzino’s sales markets increased by 20% and amounted to SEK 274.1 (229.2) million.
Faun Pharma’s external sales increased and amounted to SEK 7.1 (4.7) million.
Overall, the Group increased revenues by 20% to SEK 281.2 (233.9) million compared with the previous year.
Revenues were distributed as follows:

Regions, mSEK
26-Jan
25-Jan
Change

The Nordics
27.3
25.9
5%

Central Europe
90.1
69.4
30%

East Europe
29.4
34.2
-14%

South & West Europe
46.6
44.1
6%

The Baltics
10.5
10.4
1%

North America
41.3
21.3
94%

South America
4.0
0.9
344%

Asia-Pacific
23.0
21.5
7%

Africa
1.9
1.5
27%

Zinzino
274.1
229.2
20%

Faun Pharma
7.1
4.7
51%

Zinzino Group
281.2
233.9
20%

Countries in regions:

The Nordics: Denmark, Faroe Island, Finland, Iceland, Norway, Sweden
Central Europe: Austria, Germany, Switzerland
East Europe: Czech Republic, Slovakia, Hungary, Poland, Romania
South & West Europe: Cyprus, France, Greece, Italy, Luxembourg, Malta, Netherlands, Slovenia, Spain, United Kingdom, Belgium, Ireland, Serbia, Turkey, Canary Islands
The Baltics: Estonia, Latvia, Lithuania
North America: Canada, USA, Mexico
South America: Peru, Colombia
Asia-Pacific: Australia, Hong Kong, India, Malaysia, Singapore, Taiwan, Thailand, China, Philippines, South Korea
Africa: South Africa

About Zinzino
Zinzino AB (publ) (ZZ-B.ST) is a global direct-sales company from Scandinavia specializing in test-based, personalized nutrition and scientific skincare. It is a public limited company with its shares listed on Nasdaq First North Premier Growth Market.
Zinzino’s scientifically proven nutritional supplements are available in more than

Read more...

Zinzino Announces Merger of It Works! For Increased Distribution Power in North America and Europe

Zinzino announces merger of It Works! into the Zinzino family of businesses for increased distribution power in North America and Europe
Zinzino (publ) (ZZ-B.ST) has today entered into an agreement, and simultaneously closed, to combine with the US-based direct sales company It Works! In an all-share transaction. Through the merger, Zinzino acquired the operational assets of It Works!’ US business, including inventory, distributor agreements, customer agreements, and IP rights, as well as 100% of the shares in It Works! Marketing International UC, an Irish unlimited company, and its wholly owned subsidiaries.
The fixed purchase price amounts to USD 30 million (the “Purchase Price”) which has been paid by Zinzino through a directed set-off issue of 1,843,840 B-shares in Zinzino (the “Directed Issue”). The Directed Issue has been resolved upon by the board of directors of Zinzino, based on the authorization of the Annual General Meeting. The subscription price in the Directed Issue amounts to SEK 145.62 per B-share, which corresponds to the volume weighted average price of Zinzino’s B-share two business days prior to the signing and closing of the transaction. In addition, an additional purchase price estimated to USD 4 million could be paid to It Works! during a five-year span

Read more...

Building a Legacy After 50, When the Decision Is No Longer About Money, But About Values

Levente Okos, Zinzino Director – a conscious shift that also shapes his children’s vision of the future.

“Dad, I want to be a networker, because I want to be a free and healthy person.”

Few sentences give a parent stronger feedback than when their child not only sees, but truly understands what they are building. For Levente Okos, the stakes of the decision therefore went far beyond business: close to fifty, with more than twenty years of experience in network marketing behind him, after the closure of a company in Romania, the question was not whether he would continue in the industry, but which company, which corporate culture, and what kind of leadership were worth committing to for the next ten to fifteen years. When you have to make a change, there is no time for evasions. Either you continue out of habit, or you consciously rebuild on new foundations—so that what you create also contributes to your children’s vision of the future.

“I went out for a run, and as I often do, I was thinking about whether I really want to keep doing this, or if I’m just continuing out of habit. Network marketing itself was never in question—I’ve always loved

Read more...

Zinzino Preliminary Sales Report 2025

Zinzino group revenue increased 46% in Q4 and total revenue for the full year 2025 increased 51%, compared with the previous year.
The revenue in December for Zinzino‘s sales markets increased by 35% and amounted to SEK 334.4 (246.9) million. Faun Pharma’s external sales decreased and amounted to SEK 2.9 (5.8) million. Overall, the Group increased revenues by 33% to SEK 337.3 (252.7) million compared with the previous year.
Revenue in Zinzino’s sales markets increased by 50% in the fourth quarter of 2025 compared with the same period last year and amounted to SEK 1,032.3 (690.3) million. Total revenues in the Group increased by 46% in the fourth quarter and amounted to SEK 1,042.4 (713.5) million.
Accumulated revenue for January – December 2025 increased by 51% to SEK 3,344.5 (2,207.8) million.
Revenues were distributed as follows:

Regions, mSEK
25-Dec
24-Dec
Change
Q4 2025
Q4 2024
Change
YTD 2025
YTD 2024
Change

The Nordics
31.4
29.6
6%
98.4
88.0
12%
332.5
302.0
10%

Central Europe
102.9
78.1
32%
337.9
202.3
67%
995.4
596.7
67%

East Europe
36.3
34.5
5%
122.0
120.6
1%
398.0
400.4
-1%

South & West Europe
53.7
49.7
8%
167.8
131.9
27%
565.8
396.4
43%

The Baltics
18.0
12.0
50%
48.3
38.2
26%
133.5
107.6
24%

North America
52.0
21.1
146%
163.8
66.3
147%
545.7
200.5
172%

Asia-Pacific
37.4
20.2
85%
86.2
37.1
132%
299.4
84.6
254%

Africa
2.7
1.7
59%
7.8
5.9
32%
23.8
16.8
42%

Zinzino
334.4
246.9
35%
1,032.3
690.3
50%
3,294.1
2,105.0
56%

Faun Pharma
2.9
5.8
-50%
10.1
23.2
-57%
50.4
102.8
-51%

Zinzino Group
337.3
252.7
33%
1,042.4
713.5
46%
3,344.5
2,207.8
51%

Countries in regions:

The Nordics: Denmark, Faroe Island, Finland, Iceland, Norway, Sweden
Central Europe: Austria, Germany, Switzerland
East Europe: Czech Republic, Slovakia, Hungary, Poland, Romania
South & West Europe: Cyprus, France, Greece, Italy, Luxembourg, Malta, Netherlands, Slovenia, Spain, United Kingdom, Belgium, Ireland, Serbia, Turkey, Canary Islands
The Baltics: Estonia, Latvia, Lithuania
North America: Canada, USA, Mexico
Asia-Pacific: Australia, New Zealand, Hong

Read more...

24-Year-Old Vanda Viktoria Nagy Reaches Director Rank at Zinzino

Zinzino continues to showcase the rise of a new generation of leaders as Vanda Viktoria Nagy achieves the Director rank at just 24 years old.
Her success marks an important milestone – not only in her own career, but also as a strong signal of how the profession is opening up to younger, highly capable leaders.
Vanda’s path into network marketing was far from typical. Unlike most people in the industry, she was not introduced through an invitation, a presentation, or a company event. Instead, her journey began through everyday exposure and lived experience.
Three and a half years ago, she became part of the Kamras family—her mother-in-law is Ria Kamras, Zinzino’s first Global President leader.

Rather than being formally recruited, Vanda gradually grew into the industry. For several years, she worked behind the scenes, helping organize local team events and supporting the community, while closely observing how a large, international organization operates. This period became an intensive learning phase, giving her practical insight into leadership, structure, and long-term business building.

Six months ago, she made a clear and deliberate decision to step forward and build her own independent career within Zinzino.
While she had previously attended multiple Director trips as a family member, this

Read more...

Zinzino Sales Growth November 2025

Zinzino AB (PUBL.): Preliminary Sales Report November 2025

Zinzino group revenue increased with a total of 45 %, compared with the previous year. The revenue in November for Zinzino’s sales markets increased by 49 % and amounted to SEK 375.0 (251.8) million. Faun Pharma’s external sales decreased and amounted to SEK 4.3 (10.1) million.
Overall, the Group increased revenues by 45 % to SEK 379.3 (261.9) million compared with the previous year.
Accumulated revenue for January – November 2025 increased by 54 % to SEK 3,007.5 (1,955.1) million.
Revenues were distributed as follows:

Regions, MSEK
25-Nov
24-Nov
Change
YTD 2025
YTD 2024
Change

The Nordics
29.7
29.0
2%
301.0
272.3
11%

Central Europe
133.9
70.4
90%
892.2
518.7
72%

East Europe
51.5
51.6
0%
361.9
366.0
-1%

South & West Europe
58.7
45.3
30%
513.9
346.7
48%

The Baltics
17.3
16.1
7%
115.4
95.6
21%

North America
58.1
25.8
125%
491.0
179.2
174%

Asia-Pacific
23.0
11.1
107%
263.7
64.4
309%

Africa
2.8
2.5
12%
21.1
15.1
40%

Zinzino
375.0
251.8
49%
2960.2
1858.0
59%

Faun Pharma
4.3
10.1
-57%
47.3
97.1
-51%

Zinzino Group
379.3
261.9
45%
3007.5
1955.1
54%

Countries in regions:

The Nordics: Denmark, Faroe Island, Finland, Iceland, Norway, Sweden
Central Europe: Austria, Germany, Switzerland
East Europe: Czech Republic, Slovakia, Hungary, Poland, Romania
South & West Europe: Cyprus, France, Greece, Italy, Luxembourg, Malta, Netherlands, Slovenia, Spain, United Kingdom, Belgium, Ireland, Serbia, Turkey, Canary Islands
The Baltics: Estonia, Latvia, Lithuania
North America: Canada, USA, Mexico
Asia-Pacific: Australia, New Zealand, Hong Kong, India, Malaysia, Singapore, Taiwan, Thailand, China, Philippines, South Korea
Africa: South Africa

View as PDF
SOURCE: Zinzino
About Zinzino
Zinzino AB (publ) (ZZ-B.ST) is a global direct-sales company from Scandinavia specializing in test-based, personalized nutrition and scientific skincare. It is a public limited company with its shares listed on Nasdaq First North Premier

Read more...

Zinzino Interim Report For Q3 2025

Strong sales growth and increased profit margins drive profitability upwards
To view the full report, go to: Zinzino Interim Report Q3 2025
Revenue for the third quarter of 2025 amounted to SEK 784.1 (532.8) million, corresponding to 47% (22%) growth compared with the same period last year. In local currencies, revenue for the third quarter increased by 53% compared with the corresponding period last year.
EBITDA increased to SEK 109.7 (63.0) million after the EBITDA margin increased to 14.0% (11.8%).
The improved EBITDA margin compared to the corresponding period last year was mainly due to stronger gross profit and increased synergies, primarily related to the acquisition of Zurvita.
During the quarter, Zinzino also acquired the assets of the US-based direct sales companies Bodē Pro and Truvy to increase distribution power in North America, Latin America, South Korea and Japan.
JULY-SEPTEMBER 2025

Total revenue amounted to SEK 784.1 (532.8) million, corresponding to a growth of 47% (22%)
Gross profit amounted to SEK 277.2 (178.8) million and the gross profit margin was 35.4% (33.6%)
EBITDA amounted to SEK 109.7 (63.0) million and the EBITDA margin was 14.0% (11.8%)
Net profit amounted to SEK 89.4 (42.6) million
Net profit per share after tax before dilution amounted to SEK 2.47 (1.24)
Cash flow from operating activities

Read more...